AskTheDate.com
Back to calendar

Spyre Therapeutics, Inc. (SYRE) Earnings

SYRE reports earnings on Thursday, November 5, 2026

earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.76
Actual EPS: $-0.36
EPS surprise: 52.56%
Company overview
Market Cap$7.9B
PriceUSD 89.33
EPS (TTM)-2.18
52-week high110.17
52-week low14.51
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees102
Buy me a coffee